Semble, a provider of a care coordination software platform for outpatient healthcare providers across the UK and Europe, raised £30 million (US$40 million) in a Series C funding round.
European growth investor Revaia led the investment round with participation from Partech and existing investors Mercia Ventures and Octopus Ventures.
With in new capital, Semble is set to lead AI-driven care orchestration across Europe, building on a massive footprint that already serves 10 million+ patients—reaching 1 in every 6 people in the UK.
The investment comes as healthcare providers across the UK and Europe face mounting operational pressure caused by fragmented technology systems, rising patient demand and a generational shift towards private medical insurance and self-pay care models.
Christoph Lippuner, CEO and co-founder of Semble, said: “For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients.
He added: “What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”
As of today, Semble serves 1,700 healthcare businesses across 80 specialties and is used daily by 16,000 professionals. Its growing client list includes Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality, and ProblemShared.
Digital health companies have secured more than $180 billion in funding to date, according to our recent Funding Database. More recently, Novellia, a developer of a patient-powered real-world data and personal health records platform, raised $18 million in Series A funding, bringing its total funding to over $28 million to date.
In another deal, Garner Health, a leading digital company that helps patients find the best healthcare providers using better data and smarter financial incentives, has closed a $100 million Series E round at a valuation of $2.74 billion.